|
|
|
| Expression and Significance of mir-99b-5p, hs CRP and UA in Patients with Schizophrenia |
| CHEN Jie |
| Outpatient Department,Mental Hospital of Daxing District,Beijing,102600 |
|
|
|
|
Abstract 【Objective】 To study the changes and significance of serum miR-99b-5p, hs-CRP and UA levels in schizophrenic patients.【Methods】 From February 2015 to January 2018, 85 patients with schizophrenia (schizophrenia group), 76 patients with bipolar disorder (bipolar disorder group) and 78 healthy volunteers (control group) were prospectively selected. The serum levels of mir-99b-5p, hs CRP and UA were detected by RT-PCR, latex enhanced immunoturbidimetry and uric acid oxidase method. The value of serum mir-99b-5p, hs CRP and UA levels in the diagnosis of schizophrenia was analyzed. 【Results】 The serum levels of mir-99b-5p, hs CRP and UA in patients with schizophrenia were lower than those in patients with bipolar disorder (P<0.05). Serum mir-99b-5p level was negatively correlated with PANSS positive symptom score, general pathological score and total score (P<0.05) and positively correlated with negative symptom score (P<0.05); serum hs CRP level was positively correlated with PANSS positive symptom score, general pathological score and total score; serum UA level was positively correlated with PANSS positive symptom score and total score. Mir-99b-5p, hs CRP and UA were independent risk factors of schizophrenia. Serum mir-99b-5p and hs CRP had high value and specificity in the diagnosis of schizophrenia (P<0.05). 【Conclusion】 Mir-99b-5p and hs CRP can be used as markers of schizophrenia. The detection of serum mir-99b-5p, hs CRP and UA levels in patients with schizophrenia will be helpful for disease diagnosis and clinical treatment.
|
|
Received: 20 April 2018
|
|
|
|
|
|
[1] 王丽辉, 钟小兵, 周宪标,等. 富马酸喹硫平联合奥氮平对精神分裂症患者临床病理症状、认知功能及生活质量的影响[J].医学临床研究,2017,34(3):590-592.
[2] 李鹏辉, 郑远松, 李菲,等. 利培酮对精神分裂症患者阴性症状及认知功能的影响[J].医学临床研究,2017,34(3):582-584.
[3] Roberts J, Gracia Canales A, Blanthorn-Hazell S, et al. Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia[J].BMC Psychiatry,2018,18(1):104.
[4] Meda SA, Clementz BA, Sweeney JA, et al. Examining functional resting-state connectivity in psychosis and its subgroups in the bipolar-schizophrenia network on intermediate phenotypes cohort[J].Biol Psychiatry Cogn Neurosci Neuroimaging,2016,1(6):488-497.
[5] Kocsis RN. Diagnostic and statistical manual of mental disorders fifth edition (DSM-V)[J].Int J Offender Ther Comparat Criminol,2013,57(12):1546-1548.
[6] Kim SY, Lee BD, Park JM, et al. Transmissibility and familiality of NEO personality dimensions in a sample of Korean families with schizophrenia[J].Medicine (Baltimore),2018,97(8): e9858.
[7] Liu M, Pei G, Peng Y, et al. Disordered high-frequency oscillation in face processing in schizophrenia patients[J].Medicine (Baltimore),2018,97(6): e9753.
[8] Gon alves VF, Giamberardino SN, Crowley JJ, et al. Examining the role of common and rare mitochondrial variants in schizophrenia[J].PLoS One,2018,13(1): e0191153.
[9] 彭瑛,冯莎莎,田刚,等.血浆microRNA-107和microRNA-99b-5p对精神分裂症的诊断价值[J].山东医药,2017,57(4):98-100.
[10] Bakirhan A, Yalcin SS, Sahiner IV, et al. Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia[J].PLoS One,2017,12(12): e0189373.
[11] Attar R, Berg JM, Valentin JB, et al. Treatment following myocardial infarction in patients with schizophrenia[J].PLoS One,2017,12(12): e0189289. |
|
|
|
2020, Vol. 37 
